biostudies-literatureUnknown12(1)Passardi A<h4>Introduction</h4>ONCO-TreC platform consists of a mobile application delivered to patients as electronic diary and a web-based dashboard managed by healthcare professionals. We aim to compare the effectiveness of ONCO-TreC electronic diary with a standard paper diary, in improving adherence to oral cancer therapy in patients with solid and haematological tumours.<h4>Methods and analysis</h4>This is an open label, superiority, randomised controlled trial conducted in two Italian oncology units. Patients will be randomised with a 1:1 ratio to electronic or paper diary. For both groups a counsellor will be responsible for drug and diary delivery. The evaluation period will end after six cycles of therapy. The primary aim is to compare the proportion of non-adherent patients in the two armBMJ opene055814https://www.ebi.ac.uk/biostudies/studies/S-EPMC8753414biostudies-literatureUse of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial.PMC8753414Eccher CSullo FOberosler VSerra PMasini CGiardino VBartolini GPetracci EForti SGios LCampomori ACaffo OPassardi AVespignani RBrugugnoli EDianti MPiras EMAnesi CfalseUse of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial.<h4>Introduction</h4>ONCO-TreC platform consists of a mobile application delivered to patients as electronic diary and a web-based dashboard managed by healthcare professionals. We aim to compare the effectiveness of ONCO-TreC electronic diary with a standard paper diary, in improving adherence to oral cancer therapy in patients with solid and haematological tumours.<h4>Methods and analysis</h4>This is an open label, superiority, randomised controlled trial conducted in two Italian oncology units. Patients will be randomised with a 1:1 ratio to electronic or paper diary. For both groups a counsellor will be responsible for drug and diary delivery. The evaluation period will end after six cycles of therapy. The primary aim is to compare the proportion of non-adherent patients in the two arm2022-01-01T00:00:00Z2022 Jan2026-05-07T23:47:15.78Z2022-02-11T16:09:25.909ZS-EPMC87534143501725410.1136/bmjopen-2021-055814